These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

108 related articles for article (PubMed ID: 8936627)

  • 41. [New approaches to combined therapy of irritative symptoms in patients with benign prostatic hyperplasia].
    Ergakov DV; Martov AG
    Urologiia; 2021 May; (2):40-45. PubMed ID: 33960155
    [TBL] [Abstract][Full Text] [Related]  

  • 42. Effects of D-004, a lipid extract from the royal palm (Roystonea regia) fruits, tamsulosin and their combined use on urodynamic changes induced with phenylephrine in rats.
    Arruzazabala Mde L; Molina V; Más R; Carbajal D
    Arzneimittelforschung; 2008; 58(2):81-5. PubMed ID: 18412021
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Short-term oral treatment of canine benign prostatic hypertrophy with chlormadinone acetate.
    Orima H; Shimizu M; Tsutsui T; Kawakami E; Ogasa A
    J Vet Med Sci; 1995 Feb; 57(1):139-41. PubMed ID: 7538794
    [TBL] [Abstract][Full Text] [Related]  

  • 44. Histological evaluation of benign prostatic hyperplasia treated by long-term administration of chlormadinone acetate (CMA).
    Harada M; Kinoshita Y; Moriyama M; Kondo I; Nakahashi M; Kumagai H; Sasaki K; Hosaka M
    Prostate; 1994 Sep; 25(3):147-55. PubMed ID: 7520578
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Effects of oral administration of chlormadinone acetate on canine prostatic hypertrophy.
    Kawakami E; Tsutsui T; Shimizu M; Orima H; Makanae Y; Yajima K; Ogasa A
    J Vet Med Sci; 1993 Aug; 55(4):631-5. PubMed ID: 7691191
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Use of an alpha 1-blocker, YM617, in the treatment of benign prostatic hypertrophy. YM617 Clinical Study Group.
    Kawabe K; Ueno A; Takimoto Y; Aso Y; Kato H
    J Urol; 1990 Oct; 144(4):908-11; discussion 911-2. PubMed ID: 1697914
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Effect of chlormadinone acetate-pellet implantation on the volume of prostate, peripheral blood levels of sex hormones and semen quality in the dog.
    Shimizu M; Tsutsui T; Kawakami E; Hori T; Fujita M; Orima H; Ogasa A
    J Vet Med Sci; 1995 Jun; 57(3):395-9. PubMed ID: 7548388
    [TBL] [Abstract][Full Text] [Related]  

  • 48. [Alpha blockers, TUS-P and TUR-P in the treatment of benign prostatic hypertrophy. A comparison using multivariate statistical analysis].
    Chisena S; Mandressi A; Zaroli A; Belloni M; Antonelli D; Bernasconi S; Buizza C
    Arch Ital Urol Androl; 1995 Feb; 67(1):41-5. PubMed ID: 7538387
    [TBL] [Abstract][Full Text] [Related]  

  • 49. Effect of 4-chloro-7-trifluoromethyl-10H-benzo[4,5]furo[3,2-b]indole-1-carboxylic acid on the intraurethral pressure in a rat model of benign prostatic hyperplasia.
    Choi BR; Soni KK; Zhang LT; Lee SW; So I; Kim HK; Park JK
    Int J Urol; 2016 Mar; 23(3):259-65. PubMed ID: 26646436
    [TBL] [Abstract][Full Text] [Related]  

  • 50. Effects of the concomitant administration of tamsulosin (0.8 mg/day) on the pharmacokinetic and safety profile of theophylline (5 mg/kg): a placebo-controlled evaluation.
    Miyazawa Y; Starkey LP; Forrest A; Schentag JJ; Kamimura H; Swarz H; Ito Y
    J Int Med Res; 2002; 30(1):34-43. PubMed ID: 11921497
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Chlormadinone acetate pellet implantation plus short-term oral administration in dogs with benign prostatic hypertrophy.
    Kawakami E; Shimizu M; Orima H; Fujita M; Hori T; Tsutsui T
    Int J Androl; 1998 Apr; 21(2):67-73. PubMed ID: 9675615
    [TBL] [Abstract][Full Text] [Related]  

  • 52. [Clinical efficacy and safety of long-term administration of YM617 for urinary obstruction of the lower urinary tract].
    Yoshida O; Takeuchi H; Hida S; Tomoyoshi T; Arai Y; Okada K; Akino H; Isomatsu ; Okabe T; Fukuyama T
    Hinyokika Kiyo; 1991 Apr; 37(4):421-9. PubMed ID: 1716407
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Is there a demonstrated advantage to increase tamsulosin dosage in patients with benign prostatic hyperplasia?
    Aharony S; Lam O; Corcos J
    Urology; 2014 Aug; 84(2):493-4. PubMed ID: 25065994
    [No Abstract]   [Full Text] [Related]  

  • 54. [The concentration of Tamsulosin hydrochloride in the blood and prostatic tissue of the patients in benign prostatic hyperplasia].
    Morita M; Numahata K; Ogata Y; Suzuki K
    Nihon Hinyokika Gakkai Zasshi; 1997 May; 88(5):535-40. PubMed ID: 9184446
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Pharmacokinetics of tamsulosin in subjects with normal and varying degrees of impaired renal function: an open-label single-dose and multiple-dose study.
    Wolzt M; Fabrizii V; Dorner GT; Zanaschka G; Leufkens P; Krauwinkel WJ; Eichler HG
    Eur J Clin Pharmacol; 1998 Jun; 54(4):367-73. PubMed ID: 9696967
    [TBL] [Abstract][Full Text] [Related]  

  • 56. [Evaluation of anti-androgen therapy for benign prostatic hypertrophy by using transrectal prostatic ultrasonography].
    Kazama T; Mizuno I; Takamine T; Umeda K; Terada T; Ishikawa S; Fuse H; Katayama T
    Hinyokika Kiyo; 1990 Dec; 36(12):1423-7. PubMed ID: 1706136
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Letter to the Editor about "Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention".
    Qiang Y; Zhang Q; Feng Y; Cao Q
    World J Urol; 2024 Jul; 42(1):398. PubMed ID: 38985310
    [No Abstract]   [Full Text] [Related]  

  • 58. Letter to the editor for the article "Tamsulosin 0.8 mg daily dose in management of BPH patients with failed tamsulosin 0.4 mg monotherapy and unfit for surgical intervention".
    Yang J; Jiang X; Liao X
    World J Urol; 2024 Jul; 42(1):414. PubMed ID: 39012525
    [No Abstract]   [Full Text] [Related]  

  • 59. Long-term prevention of estrus in the bitch and queen using chlormadinone acetate.
    Tamada H; Kawate N; Inaba T; Sawada T
    Can Vet J; 2003 May; 44(5):416-7. PubMed ID: 12757134
    [TBL] [Abstract][Full Text] [Related]  

  • 60. [Evaluation of the long-term effect of anti-androgen therapy by sonometrics in patients with benign prostatic hypertrophy].
    Kimura A; Higuchi T
    Nihon Hinyokika Gakkai Zasshi; 1988 Oct; 79(10):1697-702. PubMed ID: 2471862
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.